Management of Glue Ear (OME) in Adults
For adults with persistent middle-ear effusion causing conductive hearing loss, the management approach differs fundamentally from pediatric guidelines, with intratympanic steroid therapy emerging as the most promising first-line option, while traditional ventilation tubes show disappointing outcomes and significant complications in this population 1.
Critical Distinction: Adult vs. Pediatric Management
The available clinical practice guidelines 2 specifically address pediatric OME only and explicitly do not apply to adult populations. This is a crucial pitfall—applying pediatric algorithms to adults leads to suboptimal outcomes.
Recommended Management Algorithm for Adults
Step 1: Rule Out Nasopharyngeal Carcinoma
- Mandatory nasopharyngoscopy in all adult OME cases, particularly unilateral presentations
- This is non-negotiable as nasopharyngeal carcinoma is a significant cause of adult OME
- If carcinoma is present, management focuses on the underlying malignancy
Step 2: Initial Treatment Selection (Non-Malignant Cases)
First-line: Intratympanic Steroid Therapy
- Most promising option based on current evidence 1
- Avoids the high complication rates associated with ventilation tubes in adults
- Directly addresses middle ear inflammation
Avoid as First-line: Ventilation Tubes (Grommets)
- Traditional standard treatment shows disappointing outcomes in adults 1
- Significant complications include:
- Intermittent or chronic discharge (particularly problematic)
- Persistent perforation risk
- Higher failure rates than in children
Step 3: Alternative Options if Initial Treatment Fails
Consider these evidence-based alternatives 1:
- Balloon dilatation of the Eustachian tube: Addresses underlying dysfunction mechanically
- Cortical mastoidectomy: For refractory cases with chronic inflammation
Step 4: Monitoring and Outcome Assessment
Document the following in medical records:
- Resolution of effusion (pneumatic otoscopy, tympanometry)
- Hearing improvement (audiometry showing reduction in conductive hearing loss)
- Quality of life improvements (communication ability, ear discomfort resolution)
What NOT to Do
Strong recommendations against (based on pediatric evidence that likely applies to adults):
- Systemic antibiotics 2
- Oral or intranasal steroids 2
- Antihistamines or decongestants 2
- Autoinflation devices (insufficient evidence in adults, minimal benefit even in children 3)
Key Clinical Pitfalls
- Assuming pediatric guidelines apply to adults: The pathophysiology and treatment responses differ significantly
- Defaulting to ventilation tubes: This carries unacceptably high complication rates in adults compared to children
- Missing nasopharyngeal carcinoma: Always visualize the nasopharynx in adult OME
- Using ineffective medical therapies: Antibiotics and decongestants waste time and resources
Evidence Strength Considerations
The adult OME literature is notably weaker than pediatric evidence, with the most recent comprehensive review 1 from 2025 calling for "a rethink of management" and "further research." This reflects the reality that adult OME management lacks high-quality RCT evidence and relies more on observational data and expert opinion. Given this limitation, the recommendation for intratympanic steroids represents the best available evidence while acknowledging the need for individualized clinical judgment in complex cases.
The striking difference from pediatric management—where tympanostomy tubes have strong evidence 2—underscores that age-specific approaches are essential for optimal outcomes in OME management.